| Literature DB >> 25442165 |
Caroline K Hatton1, Gary A Green2, Peter J Ambrose3.
Abstract
To help clinicians understand the risks associated with performance-enhancing drugs, this overview covers prohibited lists of substances and methods, therapeutic use exemptions, the legitimate indications and adverse effects, including for megadose and polypharmacy doping of stimulants, anabolic steroids, erythropoiesis-stimulating agents, and growth hormone and ways in which physicians or patients risk committing anti-doping rule violations inadvertently.Entities:
Keywords: Anabolic steroids; Blood doping; Dietary supplements; Growth hormone; Nonanalytical positive doping cases; Sports doping; Stimulants; Therapeutic use exemptions
Mesh：
Substances：
Year: 2014 PMID： 25442165 DOI： 10.1016/j.pmr.2014.06.013
Source DB: PubMed Journal: Phys Med Rehabil Clin N Am ISSN： 1047-9651 Impact factor: 1.784